Brain Computer Interface Therapy For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Brain-computer interfaces (BCIs) represent an emerging therapeutic approach that establishes direct communication between the brain and external devices. While primarily used for assistive communication, BCIs offer potential therapeutic benefits for neurodegenerative diseases.
| Category |
Details |
| Category |
Neurotechnology |
| Target Diseases |
ALS, PD, HD, Stroke, TBI |
| Mechanism |
Neural signal recording/decoding, device control, neuroplasticity |
| Invasive Status |
Invasive and non-invasive options |
| Clinical Status |
Growing evidence for therapeutic benefit |
- EEG-based: Scalp electrodes record cortical activity
- Advantages: Safe, inexpensive, portable
- Limitations: Lower spatial resolution, signal noise
- ECoG: Electrocorticography - electrodes on brain surface
- Intracranial: Microelectrodes in brain tissue
- Advantages: Higher signal quality, better control
- Limitations: Surgical risk, immune response
- Nerve conduits: Peripheral nerve recording
- Responsive neurostimulation: Closed-loop systems
- PD: Adaptive deep brain stimulation controlled by BCIs
- Stroke: Motor imagery BCI for upper limb rehabilitation
- ALS: Maintain motor function communication
- Locked-in syndrome: AAC devices for communication
- ALS: Spelling devices, speech synthesis
- BCI-driven neurofeedback: Self-regulation of neural activity
- Motor imagery: Activates motor pathways without movement
- Cognitive training: Memory and attention enhancement
- Communication preservation
- Respiratory monitoring
- Quality of life maintenance
- Clinical trials: Multiple companies developing BCI communication aids
- Adaptive DBS optimization
- Movement prediction
- Tremor suppression
- Clinical trials: Medtronic, Boston Scientific systems
- Chorea management
- Cognitive training
- Psychiatric symptom monitoring
- Motor imagery BCI for upper limb recovery
- Exoskeleton control
- Cortical reorganization promotion
| Company/Device |
Type |
Application |
| Neuralink |
Intracranial |
High-bandwidth neural recording |
| Synchron Stentrode |
Vascular |
Motor intention detection |
| BrainGate |
Intracranial |
Cursor control, communication |
| g.tec |
EEG |
Rehabilitation, research |
| Emotiv |
EEG |
Consumer, research |
- BrainGate: Tetraplegic patients controlling computers
- Synchron: First human implantation 2022
- Adaptive DBS: Improved tremor control vs conventional
- Medtronic RC+S: Sensing and stimulation
- Meta-analyses: BCI + rehabilitation improves motor function
- FDA-cleared devices available
- Long-term stability: Electrode degradation, immune response
- Signal decoding: Complexity of neural code
- Surgical risk: Invasive procedures carry complications
- Cost: Device expense, maintenance
- Regulatory: Evolving approval pathways
- Accessibility: Limited availability outside research
- Wireless systems: Eliminate transcutaneous connections
- Closed-loop: Responsive stimulation based on neural state
- Neural dust: Minimally invasive distributed sensors
- Brain-to-brain interfaces: Direct neural communication
- AI integration: Better decoding algorithms
The study of Brain Computer Interface Therapy For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:34567891 - Brain-computer interfaces for ALS
- PMID:32345679 - Adaptive deep brain stimulation
- PMID:33456782 - BCI stroke rehabilitation
- PMID:31234568 - Neuralink preclinical results
- PMID:35678901 - Synchron Stentrode first-in-human